The new platform will help researchers better understand cell-to-cell interactions in tumor microenvironments, benefitting future development of targeted cancer therapies
Researchers identified characteristics of donated cord blood units associated with strong clinical responses in the Phase 1/2 trial
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.